WorldUpstart and Quartermaster Science + Technology Park Launch Fall 2023 US Market Gateway Accelerator
WorldUpstart, LLC, and Quartermaster Science + Technology Park have joined forces to launch the Fall 2023 US Market Gateway Accelerator. This collaborative effort is set to support 11 outstanding international companies as they prepare to conquer the US healthcare industry.
The Launch of the US Market Gateway Accelerator
Scheduled to kick off on September 11, 2023, and conclude on November 9, 2023, with an event in Philadelphia, the Fall 2023 US Market Gateway Accelerator promises to be a game-changer for the MedTech and Life Sciences sectors. This eight-week hybrid program is designed to provide crucial guidance and resources to the selected companies, helping them navigate the intricacies of the US market.
The program’s 11 participants were carefully chosen from a highly competitive pool that included companies specializing in Digital Health, Drug Development, and Medical Devices. These companies hail from countries like Australia, France, Germany, Japan, and South Korea, representing a global wave of innovation in healthcare.
Breaking Down Barriers with Expert Guidance
The US Market Gateway Accelerator aims to support and encourage international companies entering the American market. Founder and CEO of WorldUpstart, Karina Sotnik, emphasized the program’s unique value, stating that it offers companies, “a custom strategic roadmap to break into and scale up in the US market.” This includes expert advice and mentoring from trusted industry veterans.
Fall 2023 Cohort
There is an impressive lineup of companies participating in this accelerator program:
- Benilight: Known for its flexible infrared and red light therapy devices, Benilight has already gained traction in Asia and Australia.
- Cartago Biotech: This company is working on a therapeutic solution to regenerate spinal intervertebral discs, relieving pain and promoting mobility.
- Deeplink Medical: Their IRIS platform improves medical imaging data acquisition and workflow, benefiting healthcare professionals worldwide.
- Indienov: Focused on femoral neck fracture prevention, Indienov’s CE class 1 certified device detects falls and alerts caregivers through a mobile app.
- Lattice Medical: Specializing in resorbable implants, Lattice Medical is pioneering breast reconstruction technology using a patient’s own body fat.
- MedMain: With AI-driven photo analysis software, MedMain provides fast pathological image diagnosis, enhancing telepathology and research.
- MexBrain: Their groundbreaking device extracts metals from the bloodstream during dialysis, offering a novel therapeutic solution.
- Previa Medical: Using AI technology, Previa Medical detects early sepsis symptoms and alerts providers 48 hours in advance.
- SMALTIS: This French lab specializes in microbiology and molecular biology, accelerating the development of health and wellbeing products.
- StrongRoom AI: A platform aimed at reducing adverse drug events in healthcare facilities worldwide.
- ViMREX GmbH: ViMREX is developing procedures for cancer treatment and prevention, focusing on HPV-related lesions.
The Quartermaster Science + Technology Park
This groundbreaking program will be hosted at the Quartermaster Science + Technology Park, a $250 million mixed-use commercial redevelopment in Philadelphia’s Point Breeze South Philadelphia location. The park offers a secure campus with state-of-the-art facilities and an abundance of green space, creating a conducive environment for research and development in the life sciences field.
The Fall 2023 US Market Gateway Accelerator is a testament to the boundless potential of collaboration in the MedTech and Life Sciences sectors. With the support of WorldUpstart, Quartermaster Science + Technology Park, and a cohort of innovative companies from around the world, the future of healthcare innovation in the United States looks incredibly promising.